For patients exploring GLP-1 therapy, understanding your primary care provider's prescribing capacity, experience level, and follow-up protocols is essential
Retatrutide may become an option in the future if: Its approved by the MHRA and recommended by NICE, which is likely several years away You havent responded well to existing GLP-1 medications, and a triple agonist offers a different approach worth trying The Phase 3 safety data on heart rate, irregular heartbeats, and dysesthesia are reassuring once its complete For most people in the UK, the choice now is between Wegovy and Mounjaro, supported by a structured weight management service
James specializes in helping patients improve their overall well-being, including their cardiovascular health and conditions like diabetes, high blood pressure, and sleep apnea.
With this combo: Body becomes efficient at using fat Energy levels remain stable Crashes are reduced Best Time to Take L-Carnitine on Keto 1
Like TRIUMPH-1, this is a basket trial with nested OSA/OA substudies but enrolling participants who also have type 2 diabetes